Indole Compounds in Oncology: Therapeutic Potential and Mechanistic Insights
Pharmaceuticals · 10.07.2024 · 17 (7) · 922
DOI: 10.3390/ph17070922 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 10.07.2024. Verfasst von Sara M Hassan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Biotechnology Department, Faculty of Science, Cairo University, Giza 12613, Egypt. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 183 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Research Centre, Egypt, National Research Centre, Egypt.
Abstract (Originalsprache)
Cancer remains a formidable global health challenge, with current treatment modalities such as chemotherapy, radiotherapy, surgery, and targeted therapy often hindered by low efficacy and adverse side effects. The indole scaffold, a prominent heterocyclic structure, has emerged as a promising candidate in the fight against cancer. This review consolidates recent advancements in developing natural and synthetic indolyl analogs, highlighting their antiproliferative activities against various cancer types over the past five years. These analogs are categorized based on their efficacy against common cancer types, supported by biochemical assays demonstrating their antiproliferative properties. In this review, emphasis is placed on elucidating the mechanisms of action of these compounds. Given the limitations of conventional cancer therapies, developing targeted therapeutics with enhanced selectivity and reduced side effects remains a critical focus in oncological research.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Biotechnology Department, Faculty of Science, Cairo University, Giza 12613, Egypt.
- Department of Chemistry and Biochemistry, Augusta University, Augusta, GA 30912, USA.
- Department of Biochemistry and Molecular Biology, Augusta University, Augusta, GA 30912, USA.
- Department of Pesticide Chemistry, National Research Centre, Dokki, Giza 12622, Egypt.
- Drug Bioassay-Cell Culture Laboratory, Pharmacognosy Department, National Research Centre, Dokki, Giza 12622, Egypt.
ORCID-Profile: Sara M Hassan, Alyaa Farid, Siva S Panda, Adel S Girgis
Förderung
- the National Research Centre, Egypt
- National Research Centre, Egypt
Zitieren
APA
Hassan, S. M., Farid, A., Panda, S. S., Bekheit, M. S., Dinkins, H., Fayad, W., & Girgis, A. S. (2024). Indole Compounds in Oncology: Therapeutic Potential and Mechanistic Insights. Pharmaceuticals, 17(7), 922. https://doi.org/10.3390/ph17070922
Vancouver
Hassan SM, Farid A, Panda SS, Bekheit MS, Dinkins H, Fayad W, et al. Indole Compounds in Oncology: Therapeutic Potential and Mechanistic Insights. Pharmaceuticals. 2024;17(7):922. doi:10.3390/ph17070922
BibTeX
@article{Hassan2024,
author = {Hassan, Sara M and Farid, Alyaa and Panda, Siva S and Bekheit, Mohamed S and Dinkins, Holden and Fayad, Walid and Girgis, Adel S},
title = {Indole Compounds in Oncology: Therapeutic Potential and Mechanistic Insights},
journal = {Pharmaceuticals},
year = {2024},
volume = {17},
number = {7},
pages = {922},
doi = {10.3390/ph17070922}
}
EUVIMED